Cytomegalovirus DNAemia and disease: current-era epidemiology, clinical characteristics and outcomes in cancer patients other than allogeneic hematopoietic transplantation.
Kim H TayMonica A SlavinKarin A ThurskyJulien CoussementLeon J WorthBenjamin W TehAmit KhotConstantine S TamMichelle K YongPublished in: Internal medicine journal (2021)
Patients with haematological malignancy, particularly B-cell LPD, T-cell LPD, chronic lymphocytic leukemia and multiple myeloma were frequently identified to have CMV DNAemia and disease. Lymphopenia, multiple cancer therapies, co-infection, and recent receipt of systemic corticosteroids were also commonly observed. Future studies are necessary to determine optimal identification and management of CMV in these patients. This article is protected by copyright. All rights reserved.
Keyphrases
- chronic lymphocytic leukemia
- end stage renal disease
- multiple myeloma
- bone marrow
- ejection fraction
- newly diagnosed
- stem cell transplantation
- chronic kidney disease
- papillary thyroid
- risk factors
- stem cells
- epstein barr virus
- current status
- metabolic syndrome
- mesenchymal stem cells
- young adults
- skeletal muscle
- adipose tissue
- squamous cell
- low dose
- lymph node metastasis
- cell therapy
- drug induced